Home
|
About IJMPO
|
Editorial board
|
Search
|
Ahead of print
|
Current Issue
|
Archives
|
Instructions
|
Subscribe
|
Advertise
|
Contact us
|
Login
Search Article
Advanced search
Users Online: 310
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Table of Contents
October-December 2010
Volume 31 | Issue 4
Page Nos. 103-150
Online since Friday, January 28, 2011
Accessed 56,400 times.
PDF access policy
Journal allows immediate open access to content in HTML + PDF
EPub access policy
Full text in EPub is free except for the current issue. Access to the latest issue is reserved only for the paid subscribers.
View issue as eBook
Author Institution Mapping
Issue citations
Issue statistics
RSS
Show all abstracts
Show selected abstracts
Export selected to
Add to my list
EDITORIAL
Progression-free or overall... That is the question...
p. 103
Sudeep Gupta
DOI
:10.4103/0971-5851.76189
PMID
:21584213
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
[Sword Plugin for Repository]
Beta
ORIGINAL ARTICLES
The effect of rehabilitation on quality of life in female breast cancer survivors in Iran
p. 105
M Poorkiani, A Abbaszadeh, M Hazrati, P Jafari, M Sadeghi, M Mohammadianpanah
DOI
:10.4103/0971-5851.76190
PMID
:21584214
Background:
The purpose of this study was to compare the quality of life (Qol) of female breast cancer survivors who received rehabilitation intervention beside medical care and survivors who received medical care alone.
Materials and Methods:
Fifty-seven female breast cancer survivors were assigned to usual medical care (control group) or to usual medical care plus rehabilitation intervention (experimental group). Qol of all patients was assessed before, 1 week and 3 months after intervention. The intervention consisted of physiotherapy, education and individual counseling. The authors used the European Organization for Research and Treatment of Cancer core questionnaire and breast module (EORTC QLQ-C30/BR23) for the assessment of Qol.
Results:
Patients who received rehabilitation had significantly better Qol. Overall, mean of Qol scores improved gradually in experimental group from before to 1 week and 3 months after intervention. In contrast, minimal change was observed between pre/post and follow-up measures for control group.
Conclusion:
Rehabilitation after breast cancer treatment has the potential for physical, psychological and overall Qol benefits.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (5) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Pesticides and brain cancer linked in orchard farmers of Kashmir
p. 110
Abdul Rashid Bhat, Muhammed Afzal Wani, AR Kirmani, TH Raina
DOI
:10.4103/0971-5851.76191
PMID
:21584215
Background:
The atmosphere of valley of Kashmir is ideal for fresh and dry fruit production. Millions of tons of pesticides, insecticides and fungicides (chemicals like chlorpyriphos, mancozeb, captan, dimethoate, phosalone, etc.) are being used by the orchard farmers to spray the plants, fruits and the leaves every year. The increasing trend in the incidence of primary malignant brain tumors in orchard farmers of Kashmir is alarming.
Aim:
To determine the relationship between the patients of primary malignant brain tumors and their occupation.
Materials and Methods:
Retrospectively case files along with death certificates of 432 patients of primary malignant brain tumors and 457 controls (non-tumor neurologic diseases), admitted for treatment simultaneously over a period of 4 years from January 2005 to December 2008, to the Department of Neurosurgery, Sher-I-Kashmir Institute of Medical Sciences (SKIMS), Kashmir, were studied. Follow-up and family contact was established. The serum cholinesterase activity was measured by kinetic/DGKC calorimetric method and ethylenediaminetetraacetic acid (EDTA) samples were sent to the laboratory. The results are expressed in U/l which is U/l×1000. The laboratory at SKIMS, Srinagar, and Dr Lal PathLabs at New Delhi used a reference range for serum cholinesterase as 3167-6333 U/l.
Results:
Analysis revealed that 90.04% (389 out of 432) patients were orchard-farm workers, orchard residents and orchard playing children exposed to the high levels of multiple types of neurotoxic and carcinogenic (chlorpyriphos, dimethoate, mancozeb and captan) chemicals for more than 10-20 years. About 31.9% (124 out of 389) of these from both sexes were younger than 40 years beginning exposure at an early age and had higher (<6334 U/l) serum cholinesterase (SCE) levels. The 9.96% (43 out of 432) patients were not exposed to pesticides. On the other hand, only 119 patients out of 457 controls had recorded history of pesticide exposure and 338 were unrelated to pesticides. Out of 389 patients, 71.7% (279 out of 389) were males and 28.3% (110 out of 389) including 7 members of three families, 6 were females and 1 male.
Conclusion:
All orchard-related 389 patients had high grade tumors as compared to the non-pesticide tumors. Mortality in pesticide exposed tumors was 12%. Higher levels of SCE were found in 31.9% (124 out of 389) patients and decreased levels in only 45.3% (176 out of 389) orchard-related patients. The significant case/control odds ratio (OR) of 0.28, hospital control SCE OR of 1.1 and family control SCE OR of 1.5, points the finger of suspicion toward the link between pesticides and brain cancer.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (1) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Quality of life as an outcome variable in the management of advanced cancer
p. 121
Manisha Bisht, SS Bist, DC Dhasmana, Sunil Saini
DOI
:10.4103/0971-5851.76194
PMID
:21584216
Background and Objective:
Though well recognized in the West, palliative care and quality of life are relatively newer concepts in a developing country like India. The aim of this study was to assess the effect of palliative care on pain and quality of life and to identify the association between the two.
Study Design:
Observational prospective study.
Materials and Methods:
Patients with advanced cancer, receiving palliative drug therapy, were recruited from a tertiary care hospital. City of Hope Medical Center Quality of Life Survey and visual analog scale (VAS) were used to assess the quality of life and cancer pain severity, respectively.
Results:
A total of 100 patients were included in the study. Palliative drug therapy produced a significant reduction in pain scores expressed as mean±SD in VAS [7.13±2.2 vs. 2.62±2.1 (
P
<0.001) after 1 month in 93 patients; 7.06±2.1 vs. 2.47±2.1 (
P
<0.001) after 1 month and 2.02±1.9 (
P
<0.001) after 2 months in 51 patients]. Also, significant improvement in the quality of life scores [919.78±271.3 vs. 1280.65±306.8 (
P
<0.01) after 1 month in 93 patients; 950.39±238.2 vs. 1336.67±291 (
P
<0.01) after 1 month and 1405.49±368.3 (
P
<0.01) after 2 months in 51 patients] was obtained. There was a high correlation between the average change of pain intensity and quality of life scores (
r
=−0.53,
P
<0.02). Overall, a reduction in pain resulted in significant improvement in the quality of life (
P
<0.001).
Conclusion:
This study emphasizes the role of palliative care and, more importantly, pain management in improving the quality of life of advanced cancer patients.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (4) ]
[PubMed]
[Sword Plugin for Repository]
Beta
REVIEW ARTICLES
The role of bacteria in oral cancer
p. 126
Noureen Chocolatewala, Pankaj Chaturvedi, Rushikesh Desale
DOI
:10.4103/0971-5851.76195
PMID
:21584217
Despite the widening interest in the possible association between bacteria and different stages of cancer development, our knowledge in its relation to oral cancers remains inadequate. The aim of this review article is to derive a better understanding on the role of various micro-organisms in the etiogenesis of oral cancers through all the available data on the pubmed. Different bacteria have been proposed to induce carcinogenesis either through induction of chronic inflammation or by interference, either directly or indirectly, with eukaryotic cell cycle and signaling pathways, or by metabolism of potentially carcinogenic substances like acetaldehyde causing mutagenesis. Studies have shown diversity of isolated bacterial taxa between the oral cancer tissue specimens and the control, with
Exiguobacterium oxidotolerans
,
Prevotella melaninogenica
,
Staphylococcus aureus
and
Veillonella parvula
being specific for tumorogenic tissues. Most isolates are saccharolytic and acid tolerant.
Streptococcus anginosus
, commonly linked with esophageal and pharyngeal cancers, is not of significance in oral cancers. Similarly, significant salivary specificity is noted for three bacteria, namely,
Capnocytophaga gingivalis, P. melaninogenica
, and
Streptococcus mitis
in oral cancer patients, making these species salivary markers for the early detection of oral cancers and thus improving the survival rate significantly. Also, such high degree of bacterial specificity in oral cancers has also provoked the designing of new treatment options for cancer prevention by way of vaccine delivery. However, for the success of these steps, a deeper exploration into this subject with a greater understanding is warranted.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (9) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Targeting mTOR pathway: A new concept in cancer therapy
p. 132
SH Advani
DOI
:10.4103/0971-5851.76197
PMID
:21584218
This article highlights the current knowledge of mTOR biology and provides new insights into the role of mTOR in different cancers. An active mTOR coordinates a response in cell growth directly through its effects on cell cycle regulators and indirectly by sustaining nutrient supply into the cell through the production of nutrient transporters and also through the promotion of angiogenesis. A primary way that mTOR exerts its regulatory effects on cell proliferation is by controlling the production of cyclin D1. mTOR increases the translation of hypoxia-inducible factor 1 (HIF-1)/HIF-2. The HIF transcription factors drive the expression of hypoxic stress response genes, including angiogenic growth factors such as vascular endothelial growth factor (VEGF), platelet-derived growth factor b (PDGF- b), and transforming growth factor a (TGF-a). mTOR also increases the surface expression of nutrient transporters proteins. An increase in these proteins results in greater uptake of amino acids and other nutrients by the cell leading to adequate nutrient support to abnormal cell growth and survival. There is also emerging evidence that mTOR activation may play a role in promoting cell survival through the activation of antiapoptotic proteins that contribute to tumor progression. Given that the mTOR pathway is deregulated in a number of cancers, it is anticipated that mTOR inhibitors will have broad therapeutic application across many tumor types. Until now, no treatment demonstrated Phase III evidence after disease progression on an initial VEGF-targeted therapy in advanced renal cell carcinoma. Everolimus is the first and only therapy with Phase III evidence after failure of VEGF-targeted therapy. Everolimus is a once-daily, oral inhibitor of mTOR (mammalian target of rapamycin) indicated for the treatment of advanced renal cell carcinoma in patients, whose disease has progressed on or after treatment with VEGF-targeted therapy.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (26) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Scope and limitations of minimal invasive surgery in practice of pediatric surgical oncology
p. 137
Sushmita Bhatnagar, Yogesh Kumar Sarin
DOI
:10.4103/0971-5851.76198
PMID
:21584219
Management of Solid tumors in children needs a comprehensive multimodality protocol based treatment plan. Open surgical removal of the tumors occurring in any of the sites such as abdomen, thorax, chest wall, HFN (head, face, neck), brain and extremities, is the option which has been traditionally practiced even in the present era and in most of the centers. Nevertheless with the advances in science and technology and with ever increasing usage and expertise of laparoscopy in children, it's application has extended to treatment of solid tumors in children. A review of the scope of such intervention as well as the limitations of minimal invasive surgery in this specialized field of pediatric surgery has been attempted in this article.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (2) ]
[PubMed]
[Sword Plugin for Repository]
Beta
SHORT DRUG REVIEW
Bortezomib
p. 143
Senthil Rajappa
DOI
:10.4103/0971-5851.76199
PMID
:21584220
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
[Sword Plugin for Repository]
Beta
LABORATARY INSIGHTS
Role of immunohistochemistry in lymphoma
p. 145
I Satish Rao
DOI
:10.4103/0971-5851.76201
PMID
:21584221
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
[Sword Plugin for Repository]
Beta
CASE REPORT
Staring secondaries, where is the primary?
p. 148
P Shanmuga Sundaram, S Padma, Jay Kumar Rai, Vijay Harish
DOI
:10.4103/0971-5851.76202
PMID
:21584222
An asymptomatic issueless young staff nurse underwent pre-employment health screening and USG abdomen showed multiple hypodense lesions in liver. Further screening with whole body positron emission tomography-computed tomography (PET-CT) scan showed significantly FDG avid mass involving most of the right lobe of liver with multiple large FDG avid lymph nodal metastases. Unsuspected focal abnormal, FDG avid, hyperdense mural nodule was seen in uterus, which is the site of primary.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
[Sword Plugin for Repository]
Beta
Feedback
Subscribe
Next Issue
Previous Issue
Sitemap
|
What's New
|
Feedback
|
Disclaimer
© Indian Journal of Medical and Paediatric Oncology | Published by Wolters Kluwer -
Medknow
Online since 1
st
June, 2009